How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

8,213 results for

Medication Causes of Headache

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. TSH secreting adenoma: a rare cause of severe headache (PubMed)

TSH secreting adenoma: a rare cause of severe headache 27200112 2017 01 17 2018 12 02 1937-8688 23 2016 The Pan African medical journal Pan Afr Med J TSH secreting adenoma: a rare cause of severe headache. 2 10.11604/pamj.2016.23.2.8451 Olt Serdar S Adıyaman University Medical Faculty Department of Internal Medicine, Adıyaman, Turkey. Şirik Mehmet M Adıyaman University Medical Faculty Department of Radiology, Adıyaman, Turkey. eng Case Reports Journal Article 2016 01 08 Uganda Pan Afr Med J (...) 101517926 9002-71-5 Thyrotropin IM Adenoma diagnostic imaging metabolism pathology Adult Headache etiology Humans Male Pituitary Neoplasms diagnosis metabolism pathology Severity of Illness Index Thyrotropin metabolism TSH secreting adenoma hyperthyroïdism severe headache 2015 11 17 2016 01 03 2016 5 21 6 0 2016 5 21 6 0 2017 1 18 6 0 epublish 27200112 10.11604/pamj.2016.23.2.8451 PAMJ-23-2 PMC4856513

Full Text available with Trip Pro

2016 The Pan African medical journal

22. Thunderclap Headache Caused by an Inadvertent Epidural Puncture During Oxygen-ozone Therapy for Patient with Cervical Disc Herniation (PubMed)

Thunderclap Headache Caused by an Inadvertent Epidural Puncture During Oxygen-ozone Therapy for Patient with Cervical Disc Herniation 26879031 2017 02 01 2018 11 13 2542-5641 129 4 2016 Feb 20 Chinese medical journal Chin. Med. J. Thunderclap Headache Caused by an Inadvertent Epidural Puncture During Oxygen-ozone Therapy for Patient with Cervical Disc Herniation. 498-9 10.4103/0366-6999.176080 Liu Hui H Wang Yong Y An Jian-Xiong JX Department of Anesthesiology, Weifang Medical University (...) , Weifang, Shandong 261000; Department of Anesthesiology, Pain Medicine and Critical Care Medicine, Aviation General Hospital of China Medical University and Beijing Institute of Translational Medicine, Chinese Academy of Sciences, Beijing 100012, China. Williams John P JP Cope Doris K DK eng Case Reports Letter China Chin Med J (Engl) 7513795 0366-6999 66H7ZZK23N Ozone S88TT14065 Oxygen IM Epidural Space Female Headache Disorders, Primary etiology Humans Intervertebral Disc Displacement drug therapy

Full Text available with Trip Pro

2016 Chinese medical journal

23. Headache Causes

Headache Causes Headache Causes Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Headache Causes Headache Causes Aka: Headache Causes (...) , Primary Headache From Related Chapters II. Epidemiology : 50% of U.S. adults suffer from s at any period of time III. Causes: Urgent Headaches Dissection Dissection Acute angle closure IV. Causes: Primary Headaches See See Chronic Nonprogressive Common s (50% of acute s) Common (10% of acute s) Other Primary Headaches ( ) V. Causes: Secondary Headaches See (e.g. ) Myofacial pain disorder ( ) Ophthalmologic (severe ) See See ( ) See s Life-treatening secondary causes or Acute or chronic Cerebellar

2018 FP Notebook

24. Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment

(RCT) design. Condition or disease Intervention/treatment Phase Secondary Headache Disorders Medication-overuse Headache Behavioral: Educational programme Not Applicable Detailed Description: Worldwide, two percent of the population suffers from medication-overuse headache (MOH), a paradox condition where the headache is caused by overuse of headache medication. Common treatment is withdrawal, but there is no consensus on what constitutes the best treatment. The study consists of a RCT with MOH (...) Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2016 Clinical Trials

25. Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers

Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers (ALGEA) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02734992 Recruitment Status : Unknown Verified April 2016

2016 Clinical Trials

26. The Heterogeneity Of Headache Patients Who Self-Medicate: A Cluster Analysis Approach. (PubMed)

The Heterogeneity Of Headache Patients Who Self-Medicate: A Cluster Analysis Approach. Patients with headache often self-treat their condition with over-the-counter analgesics. However, overuse of analgesics can cause medication-overuse headache. The present study aimed to identify subgroups of individuals with headache who self-medicate, as this could be helpful to tailor intervention strategies for prevention of medication-overuse headache. Patients (n = 1021) were recruited from 202 (...) community pharmacies and completed a self-administered questionnaire. A hierarchical cluster analysis was used to group patients as a function of sociodemographics, pain, disability, and medication use for pain. Three patient clusters were identified. Cluster 1 (n = 498, 48.8%) consisted of relatively young individuals, and most of them suffered from migraine. They reported the least number of other pain complaints and the lowest prevalence of medication overuse (MO; 16%). Cluster 2 (n = 301, 29.5

Full Text available with Trip Pro

2016 Pain

27. Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population. (PubMed)

effects compared with other forms.The frequency of migraine headache was decreased with medical marijuana use. Prospective studies should be conducted to explore a cause-and-effect relationship and the use of different strains, formulations, and doses of marijuana to better understand the effects of medical marijuana on migraine headache treatment and prophylaxis.© 2016 Pharmacotherapy Publications, Inc. (...) Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population. No clinical trials are currently available that demonstrate the effects of marijuana on patients with migraine headache; however, the potential effects of cannabinoids on serotonin in the central nervous system indicate that marijuana may be a therapeutic alternative. Thus, the objective of this study was to describe the effects of medical marijuana on the monthly frequency of migraine headache.Retrospective

Full Text available with Trip Pro

2016 Pharmacotherapy

28. CRACKCast E020 – Headaches

CRACKCast E020 – Headaches CRACKCast E020 - Headaches - CanadiEM CRACKCast E020 – Headaches In , , by Adam Thomas December 29, 2016 This episode of CRACKCast covers Chapters 20 of Rosen’s Emergency Medicine, Headaches. This episode reviews the common and life threatening causes of headaches, and dives into red flags you cannot miss when assessing these patients on your next shift. Shownotes – Rosen’s in Perspective: Epidemiology 90% of people in the US have headaches most patients visiting ED (...) have benign headaches: Tension – 50% NYD – 30% Migraine – 10% Secondary headache – 8% <1% of those with secondary headaches have life threatening causes Pathophysiology ***the brain parenchyma is insensitive to pain*** The pain sensitive areas: Meninges Blood vessels Tissues lining the cavities within the skull *this leads to inaccurate localization of pain **most of the pain associated with h/a is mediated through Cranial Nerve V this is then transferred back to the nucleus and then radiated

2016 CandiEM

29. Paracetamol is a weak painkiller for regular tension headaches

tension-type headache may consider alternatives and patients should be made aware that sustained use of paracetamol may cause medication overuse headache. Share your views on the research. Why was this study needed? Tension-type headache is the most common type of headache, affecting 21% of people worldwide. These headaches are characterised by pressing or tightening pain (non-pulsating) of mild-to-moderate intensity on both sides of the head. Frequent episodic tension-type headache is diagnosed when (...) to the possibility of medication overuse headache in people whose headache developed or worsened while taking paracetamol on at least 15 days per month over a period of three months or more. What are the implications? This review suggests that paracetamol has a minimal effect on relieving pain in people with frequent tension-type headache compared to placebo. However, the drug is very cheap and available over-the-counter, which is of importance to patients given that many with this type of headache do not seek

2018 NIHR Dissemination Centre

30. Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache

of BoNT with other headache preventive treatments. One Class III study e15 demonstrated similar efficacy for onaBoNT-A and topiramate in CM. No other studies comparing oral preventive medications with BoNT injections met inclusion criteria. There also are no studies comparing different BoNT serotypes in headache. AEs of onaBoNT-A included neck pain and muscle weakness. Conclusions. OnaBoNT-A is established as safe and effective for reducing the number of headache days in CM (2 Class I studies (...) Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share May 10, 2016 ; 86 (19) Special Article Practice guideline update summary

2016 American Academy of Neurology

31. Headaches in over 12s: diagnosis and management

, for example, headaches associated with medication overuse, giant cell arteritis, raised intracranial pressure and infection. Medication overuse headache most commonly occurs in those taking medication for a primary headache disorder. The major health and social burden of headaches is caused by primary headache disorders and medication overuse headache. This guideline makes recommendations on the diagnosis and management of the most common primary headache disorders in young people (aged 12 years and older (...) for implementation 4 T ension-type headache, migraine and cluster headache 4 Medication overuse headache 4 Management 4 Recommendations 8 1.1 Assessment 8 1.2 Diagnosis 9 1.3 Management 14 T erms used in this guideline 19 Context 23 More information 23 Recommendations for research 24 1 Amitriptyline to prevent recurrent migraine 24 2 Pizotifen to prevent recurrent migraine 24 3 T opiramate to prevent recurrent cluster headache 25 4 Psychological interventions to manage chronic headache disorders 25 5

2012 National Institute for Health and Clinical Excellence - Clinical Guidelines

32. Medication-overuse headache: finally, we have an intervention that works.

Medication-overuse headache: finally, we have an intervention that works. Medication-overuse headache: finally, we have an intervention that works. | JNNP blog by Headache. Common, painful, frustrating, exhausting- and that’s just what the neurologist feels when a headache patient walks in the room. The patients themselves are often at their wits end as headache, whatever the cause, is often functional incapacitating and can really ruin quality of life. Of all the headache types that are seen (...) in neurology, medication-overuse headache (MOH) can be particularly challenging. The condition typically occurs in patients who take frequent large quantities of acute headache treatments, including over-the –counter drugs. The problem here is that these patients often are taking these tablets for another headache condition such as migraine. After taking large amounts of these acute treatments over long periods of time, their migraine symptoms often tend to morph with MOH symptoms and it can be very hard

2015 JNNP blog

33. Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine

include changes in the number and severity of cluster headache or migraine episodes, medication use, quality of life in the short and long term, side effects, acceptability, and device durability. NICE may update this guidance on publication of further evidence. 2 2 Indications and current treatments Indications and current treatments 2.1 Cluster headaches are characterised by episodes of unilateral periorbital pain, conjunctival injection, lacrimation and rhinorrhoea. Attacks can last from a few (...) Disorders classifies migraine types. Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine (IPG552) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 92.2 The usual treatment option for patients with cluster headache or migraine is medical therapy, either to stop or prevent attacks. Treatments for acute cluster headache attacks include oxygen inhalation and medications

2016 National Institute for Health and Clinical Excellence - Interventional Procedures

34. Pneumonia caused by proton pump inhibitors (PPI)

team is summarised as follows: (1)Tamiflu did not reduce hospitalization and pneumonia in patients with influenza. (2) Tamiflu did not reduce influenza-like illness when used for prophylaxis. (3) Tamiflu did not reduce death either. (4) Tamiflu caused psychiatric harm both in treatment trials and in prophylaxis trials. It caused headache, diabetes and renal disease. The decision of WHO has some limitations. First, neuropsychiatric harm including abnormal Editorial C M ED HECK -The Informed (...) Pneumonia caused by proton pump inhibitors (PPI) MED CHECK - TIP December 2017 / Vol.3 No.9 · Page 27 -The Informed Prescriber C N o 9 M ED HECK D e ce m b e r 2 0 1 7 WHO downgrades Tamiflu Suvorexant : A hypnotic causing cataplexy Insomnia, Sleep Duration, Harm of hypnotics PPI causes Pneumonia Editorial WHO downgraded oseltamivir (Tamiflu) New Products Hypnotic (sleeping pill), suvorexant (brand name Belsomra) A substance that causes narcolepsy and cataplexy Teriparatide More harm than

2018 Med Check - The Informed Prescriber

35. Rhinogenic headache in pediatric and adolescent patients: an evidence-based review. (PubMed)

Rhinogenic headache in pediatric and adolescent patients: an evidence-based review. Although some causes of rhinogenic headache, such as acute sinusitis, have clear diagnostic criteria, others, such as "sinus headache" and mucosal contact points, are more nebulous. Misdiagnosis of these entities and primary headaches may result in unnecessary medical or surgical treatment. The purpose of this systematic review is to delineate current understanding of diagnosis and treatment of rhinogenic (...) headaches, including sinus and mucosal contact point headaches, in children.PubMed, SCOPUS, and the Cochrane databases were searched for studies on sinus headache and mucosal contact point headaches in children. Studies were assessed for level of evidence, and risk of bias was assessed by Methodological Index for Non-Randomized Studies (MINORS) scoring. Diagnostic criteria, management strategies, and other clinical data were analyzed.Eight studies met the inclusion criteria. Level of evidence

2019 International forum of allergy & rhinology

36. Is septoplasty effective rhinogenic headache in patients with isolated contact point between inferior turbinate and septal spur? (PubMed)

Is septoplasty effective rhinogenic headache in patients with isolated contact point between inferior turbinate and septal spur? Rhinogenic headache is a painful sensation in the head and face due to intranasal contact point without any mass or inflammatory findings. Surgery is recommended in patients with nasal obstruction; however the approach in case of isolated mucosal contact point that does not cause obstruction is controversial. Our aim is to observe changes in the severity of headache (...) was recommended to the patients with no satisfactory relieve of headache. Visual Analog Scales (VAS) were used to evaluate the severity of headache in patients at time of diagnosis (0 month), after a medical treatment (1st month) and after a surgical or medical treatment (6th month). The results were compared with each other statistically.There was a decrease in VAS values after a month of medical treatment in all patients with isolated contact point (Z = -8.352; p = 0.0). VAS values significantly improved

2019 American Journal of Otolaryngology

37. MKSAP: 81-year-old woman with headaches, redness of the face, and itching

MKSAP: 81-year-old woman with headaches, redness of the face, and itching JAK2 V617F mutation is present in 97% of patients with polycythemia vera MKSAP: 81-year-old woman with headaches, redness of the face, and itching | | March 2, 2019 1 Shares Test your medicine knowledge with the , in partnership with the . An 81-year-old woman is evaluated for a 1-year history of headaches, redness of the face, and itching. She indicates being otherwise capable of performing her daily activities on her (...) farm. She reports no shortness of breath, chest pain, or difficulty sleeping. Medical history is significant for hypertension; she has never smoked and does not drink alcohol. Her only medication is hydrochlorothiazide. On physical examination, vital signs are normal except for a blood pressure of 160/90 mm Hg; BMI is 19. Abdominal examination shows splenomegaly. Laboratory studies: Erythropoietin Undetectable Hemoglobin 17.5 g/dL (175 g/L) Leukocyte count 11,000/µL (11 × 10 9 /L) Platelet count

2019 KevinMD blog

38. Transcranial Magnetic and Direct Current Stimulation (TMS/tDCS) for the Treatment of Headache: A Systematic Review. (PubMed)

Transcranial Magnetic and Direct Current Stimulation (TMS/tDCS) for the Treatment of Headache: A Systematic Review. Headache is among the most prevalent causes of disability worldwide. Non-pharmacologic interventions, including neuromodulation therapies, have been proposed in patients who are treatment resistant or intolerant to medications.To perform a systematic review on the use of transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) for the treatment (...) , rTMS is most promising with moderate evidence that it contributes to reductions in headache frequency, duration, intensity, abortive medication use, depression, and functional impairment. However, only few studies reported changes greater than sham treatment. Further high-quality RCTs with standardized protocols are required for each specific headache disorder to validate a treatment effect. Registration Number: PROSPERO 2017 CRD42017076232.© 2019 American Headache Society.

2019 Headache

39. Management of Cancer Medication-Related Infusion Reactions

, the administration of prophylactic medications is key. Appropriate clinical assessment of IRs is necessary to ensure optimal management. Anticancer medications causing reactions should be discontinued in patients who are likely to experience a severe, potentially life-threatening reaction upon re-challenge. 2–5 In some cases, equally effective alternatives are available, and treatment can be switched. In other cases, it may be safe to re-challenge with the offending agent at reduced rates, with additional pre (...) the possible factors that may increase a patient’s risk for experiencing a reaction. There are classes of agents that are more likely to cause an IR, including taxanes (paclitaxel, docetaxel, cabazitaxel), platinum compounds (carboplatin, oxaliplatin, cisplatin), monoclonal antibodies (rituximab, daratumumab and obinutuzumab), and epipodophyllotoxins (etoposide). 4 Concomitant medications may alter the risk for an IR, as seen with carboplatin. The incidence of IR was higher in patients receiving

2019 Cancer Care Ontario

40. Prescription medication use in a chiropractic training clinic: Cause for vigilance. (PubMed)

Prescription medication use in a chiropractic training clinic: Cause for vigilance. The concurrent use of CAM therapies with traditional allopathic medical practice is increasing. This study investigates the concurrent use of prescription medication in patients attending a chiropractic student teaching clinic for the first time. The need for practitioners to be aware of the side effects of prescribed medication patients are using is discussed.Cross-sectional study of 1008 new patient (...) consultations at a university chiropractic teaching clinic.549 prescription medications being used by 330 patients were included in the analysis. A total of 104 individual medications were identified of which 69 listed headache as a potential side effect of their use. 57 of 116 (49%) of patients seeking care for the treatment of headache were concurrently using these medications.Patients presenting to the university chiropractic teaching clinic may be seeking care for symptoms attributed to prescription

2016 Complementary Therapies in Clinical Practice

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>